HomeInsights52 Week Low Stocks

Bliss Gvs Pharma Ltd 52 Week Low

Bliss Gvs Pharma Ltd 52 Week Low

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

48.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

YEARLOW

₹ 92.25

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week Low of Bliss GVS Pharma Ltd is ₹ 92.25 as of 22 Nov 24 .

Company Fundamentals for Bliss GVS Pharma Ltd

No data available

Market Price of Bliss GVS Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024131.5
21 Nov 2024129
19 Nov 2024120.75
18 Nov 2024121.65
14 Nov 2024117.95
13 Nov 2024116.35
12 Nov 2024118.7
11 Nov 2024121.2
08 Nov 2024124.15
07 Nov 2024126.55

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...

Read more

18 Oct 202410:48

News

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...

Read more

04 Oct 202418:37

News

Bliss GVS Pharma to convene board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2...

Read more

18 Jul 202411:35

News

Bliss GVS Pharma to convene AGM

Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will b...

Read more

04 May 202416:04

News

Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...

Read more

03 May 202410:36

News

Bliss GVS Pharma announces board meeting date

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 2 May 202...

Read more

26 Apr 202411:02

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Bliss GVS Pharma Ltd

Why is it important to track the 52-week low of Bliss GVS Pharma Ltd stocks?

Investors should monitor the 52-week low of Bliss GVS Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Bliss GVS Pharma Ltd stocks hitting a 52-week low?

Factors leading to Bliss GVS Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Bliss GVS Pharma Ltd stocks when they hit a 52-week low?

Buying Bliss GVS Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Bliss GVS Pharma Ltd stocks?

Investors should monitor the 52-week low of Bliss GVS Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Bliss GVS Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Bliss GVS Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Bliss GVS Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Bliss GVS Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Bliss GVS Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*